Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors
about
Getting to 90-90-90 in paediatric HIV: What is needed?Trends in hospitalizations among children and young adults with perinatally acquired HIV.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenKidney disease in children and adolescents with perinatal HIV-1 infection.Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.Update on tenofovir toxicity in the kidney.Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review.A review of renal disease in children with HIV infection.Respiratory Syncytial Virus in Children with Influenza-like Illness.Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years.Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
P2860
Q30385352-E6AFA591-0A0F-47C1-ACFD-71686857A2FEQ34432664-DD0DCFEE-BD68-4D9E-A129-DE535C222240Q34736194-EFBA95C6-C6B7-4660-8B18-4EB9D3F65244Q36349683-F8544C55-39FC-4C92-AB4C-A1AC0328B9FCQ36942310-E387B584-5A55-47B0-8F29-25B1F3AA3B04Q37238911-FEB93928-87EA-49DC-A210-46B342CD96D2Q38033446-97F7FD53-E37A-483B-AB51-BCC8886CF571Q38222708-FC09BB16-C1E8-49EC-B874-3C863D7B347CQ38675944-95BD2AF5-73D9-4CB8-9AF2-34276AA3D6C9Q40051368-F0AD54B0-342C-4EC7-B6FA-B7183325251AQ41269070-430B7054-4CEE-43DE-AF30-D3A7435EEA18Q41344883-FF265D08-07C9-4A29-AEAA-70EC52CE2867Q41597280-B53EB729-5231-48C5-B867-36574FF26670Q44405037-9B0803DB-07BD-4436-A256-89BB26509F2E
P2860
Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Renal function in HIV-infected ...... marate and protease inhibitors
@ast
Renal function in HIV-infected ...... marate and protease inhibitors
@en
Renal function in HIV-infected ...... marate and protease inhibitors
@nl
type
label
Renal function in HIV-infected ...... marate and protease inhibitors
@ast
Renal function in HIV-infected ...... marate and protease inhibitors
@en
Renal function in HIV-infected ...... marate and protease inhibitors
@nl
prefLabel
Renal function in HIV-infected ...... marate and protease inhibitors
@ast
Renal function in HIV-infected ...... marate and protease inhibitors
@en
Renal function in HIV-infected ...... marate and protease inhibitors
@nl
P2093
P2860
P50
P356
P1476
Renal function in HIV-infected ...... marate and protease inhibitors
@en
P2093
Donato Amodio
Giuseppe Pontrelli
Hyppolite K Tchidjou
Paola Zangari
Stefania Baldassari
P2860
P2888
P356
10.1186/1471-2334-12-18
P577
2012-01-23T00:00:00Z
P5875
P6179
1009065138